Grant RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• Autoimmune Features of Neurodegenerative Disorders
• Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PAD
• Automated Clinic Blood Pressure Assessment and Detection of White Coat and Masked Hypertension Study in African Americans
• Automated Orientation and Mobility Training in Virtual Reality for Low Vision Rehabilitation
• Automating Delirium Identification and Risk Prediction in Electronic Health Records
• Automotive Research Center Phase V - Cooperative Agreement
• Automotive Research Center Phase V - Cooperative Agreement # 3.A88
• Automotive Research Center Phase V - Cooperative Agreement #1.A82
• Automotive Research Center Phase V - Cooperative Agreement #1.A83
• Automotive Research Center Phase V - Cooperative Agreement #3.A84
• Automotive Research Center Phase V - Cooperative Agreement #3.A86
• Automotive Research Center Phase V - Cooperative Agreement #4.A87
• Autonomous Vehicle Interactive Dynamics and Morphing with Mobility & Maneuver-Self-Learning-and-Improvement
• Autophagy and PGC1-alpha Dependent Mitochondrial Biogenesis are Essential to Prevent Cardiac Reperfusion Injury
• Autophagy-Dependent Cardioprotection in Ischemia/Reperfusion Injury
• Autophagy-Lysosome Pathway Function in HIV: Effects of Antiretroviral Therapy and Relevance to Neurocognitive Status
• Award for a Mental Health Coordinator
• Award for a Physical Therapist
• AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease
• Azithromycin to Prevent BPD in Ureaplasma-infected Preterms
• Azithromycin to Prevent BPD in Ureaplasma-Infected Preterms
• Azithromycin to Prevent BPD in Ureaplasma-Infected Preterms: A Multi-Dose PK and Efficacy Trial
• B Cell Intrinsic Interferon-beta Regulates Autoreactive B Cell Development
• B Cell Subsets and Infectious Immunity to Cryptococcosis
• B Cells in Health and Disease
• B Cells in Health and Disease
• B-Cell Control Point Dysregulation in African Americans with SLE
• B-Cell Depletion by Anti-CD20 (Rituximab) in Renal Allograft Recipients Who Develop De Novo Anti-HLA Alloantibodies will Result in Inhibition of Alloantibody Production and Attenuation of Chronic Humoral Rejection (CTOT-02/CCTPT-02)
• B8 Cohesive Systems & First Class Pre-K Evaluation
• Baby and Early Childhood Endocrine Factors and Growth in Cystic Fibrosis (BEGIN) Study

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...